What is the ticker symbol for Taiwan Liposome?

Taiwan Liposome trades under the ticker TLC on NASDAQ.

What sector does Taiwan Liposome operate in?

Taiwan Liposome is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TLC in a portfolio?

PortView shows TLC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Taiwan Liposome (TLC) Stock Analysis

NASDAQHealthcareBiotechnology

$7.00+0.00%

1-year price historyRange $6.93 – $7.53

52-week range$7.00

$4.07$7.70

What Taiwan Liposome does

Taiwan Liposome Company, Ltd. (NASDAQ: TLC) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

0.80

Dividend yield

0.00%

Revenue / share

$2.58

50-day avg

$7.16

200-day avg

$6.37

52-week high

$7.70

52-week low

$4.07

CEO

Keelung Hong

ETFs linked to TLC

Broad-market and Healthcare sector ETFs an investor holding Taiwan Liposome is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TLC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TLC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Taiwan Liposome?: Taiwan Liposome trades under the ticker TLC on NASDAQ.
Which exchange is TLC listed on?: TLC is listed on NASDAQ.
What sector does Taiwan Liposome operate in?: Taiwan Liposome is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TLC in a portfolio?: PortView shows TLC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.